Identification and isolation of murine antigen‐reactive T cells according to CD154 expression

T helper (Th) cells are central regulators of adaptive immune responses. However, the detection of the small number of Th cells specific for a particular antigen or pathogen is still a major challenge. CD154 was recently introduced as a marker for antigen‐specific Th cells. To date, this technology was not applicable for mice – arguably the most important immunological model system. CD154 is difficult to detect due to its rapid removal from the cell surface upon binding to CD40 during antigen‐specific activation by APC. We present an efficient strategy to block the degradation of murine CD154 by combined use of antibodies against CD40 and CD154. This strategy makes CD154 easily accessible for surface staining, which allows isolation and expansion of rare antigen specific T cells. Importantly, CD154 identified all specific T cells in strongly Th1‐ or Th2‐polarized immune responses against pathogens like Salmonella typhimurium and Heligmosomoides polygyrus, independent of their potential to produce cytokines. We demonstrate that CD154 can in fact be used as a reliable marker for antigen‐specific CD4 T cells in mice, offering a unique option to analyze, isolate and rapidly expand the entire pool of Th‐cells generated during a physiological T cell response in vivo.

[1]  O. Sharma,et al.  Frontiers in peptide–MHC class II multimer technology , 2002, Nature Immunology.

[2]  Andreas Radbruch,et al.  Enrichment and detection of live antigen‐specific CD4+ and CD8+ T cells based on cytokine secretion , 1999, European journal of immunology.

[3]  A. Scheffold,et al.  Analysis and sorting of T cells according to cytokine expression. , 1998, European cytokine network.

[4]  F. Finkelman,et al.  Interleukin‐4‐ and interleukin‐13‐mediated host protection against intestinal nematode parasites , 2004, Immunological reviews.

[5]  W. Lee,et al.  Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Kroczek,et al.  A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation , 1995, European journal of immunology.

[7]  Leo Lefrançois,et al.  Initial T cell frequency dictates memory CD8+ T cell lineage commitment , 2005, Nature Immunology.

[8]  G. Galbraith.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2008 .

[9]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[10]  Andreas Thiel,et al.  Direct access to CD4+ T cells specific for defined antigens according to CD154 expression , 2005, Nature Medicine.

[11]  P. Marrack,et al.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. , 1998, Immunity.

[12]  G. Inghirami,et al.  CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. , 1994, Journal of immunology.

[13]  D. Busch,et al.  Coordinate regulation of complex T cell populations responding to bacterial infection. , 1998, Immunity.

[14]  R. Kroczek,et al.  The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. , 2001, Blood.

[15]  C. Pitcher,et al.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.

[16]  Y. Misumi,et al.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. , 1986, The Journal of biological chemistry.

[17]  P. Mastroeni.  Immunity to systemic Salmonella infections. , 2002, Current molecular medicine.

[18]  J. Schneider-Mergener,et al.  T-cell epitope mapping by flow cytometry , 1998, Nature Medicine.

[19]  C. Larsen,et al.  Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation , 2007, The Journal of experimental medicine.

[20]  A. Khoruts,et al.  Use of adoptive transfer of T‐cell antigen‐receptor‐transgenic T cells for the study of T‐cell activation in vivo , 1997, Immunological reviews.

[21]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[22]  A. Scheffold,et al.  Antigen-specific cytometry--new tools arrived! , 2004, Clinical immunology.

[23]  A. Khoruts,et al.  Naïve and Memory CD4+ T Cell Survival Controlled by Clonal Abundance , 2006, Science.

[24]  G. B. Cohen,et al.  Isolation of viable antigen-specific CD4 T cells by CD40L surface trapping. , 2005, Journal of immunological methods.

[25]  G. Nepom.  MHC multimers: expanding the clinical toolkit. , 2003, Clinical immunology.

[26]  C. Bona,et al.  Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras. , 2001, Protein engineering.

[27]  P. Marrack,et al.  CD8 T cell competition for dendritic cells in vivo is an early event in activation , 2006, Proceedings of the National Academy of Sciences.

[28]  S Miltenyi,et al.  Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Mario Roederer,et al.  A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles , 2005, Nature Medicine.

[30]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.